Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Mol Biochem Parasitol. 2010 Dec 30;176(2):98–108. doi: 10.1016/j.molbiopara.2010.12.009

Fig. 6.

Fig. 6

A) Model of LmajGSK-3 short with CDK 1/2 inhibitor III showing sidechain interactions to Arg 109 and backbone interactions to Glu 101, Val 103, and Ala 26. B) Model of LmajGSK-3 short with GW8510 showing similar interactions as in CDK 1/2 inhibitor III, but with additional backbone interactions to Met 25.